Oragenics Inc (OGEN)
1.09
0.00 (0.00%)
USD |
NYAM |
Apr 24, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 20:00
Oragenics Cash from Financing (Quarterly): -0.1806M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.1806M |
| September 30, 2023 | 0.7321M |
| June 30, 2023 | -0.1079M |
| March 31, 2023 | -0.1598M |
| December 31, 2022 | -0.088M |
| September 30, 2022 | -0.1035M |
| June 30, 2022 | -0.1222M |
| March 31, 2022 | -0.1812M |
| December 31, 2021 | -0.779M |
| September 30, 2021 | 0.5783M |
| June 30, 2021 | 0.1523M |
| March 31, 2021 | 23.19M |
| December 31, 2020 | 11.23M |
| September 30, 2020 | 5.080M |
| June 30, 2020 | 0.0897M |
| March 31, 2020 | -0.073M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0736M |
| September 30, 2019 | -0.05M |
| June 30, 2019 | -0.13M |
| March 31, 2019 | 11.35M |
| December 31, 2018 | 9.439M |
| September 30, 2018 | 12.39M |
| June 30, 2018 | 1.464M |
| March 31, 2018 | -0.0416M |
| December 31, 2017 | 4.602M |
| September 30, 2017 | 2.174M |
| June 30, 2017 | 1.679M |
| March 31, 2017 | -0.005M |
| December 31, 2016 | 0.9394M |
| September 30, 2016 | 0.9499M |
| June 30, 2016 | 2.596M |
| March 31, 2016 | -0.0339M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.779M
Minimum
Dec 2021
23.19M
Maximum
Mar 2021
2.053M
Average
-0.0736M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Palatin Technologies Inc | 4.974M |
| Inogen Inc | -0.014M |
| Cyclacel Pharmaceuticals Inc | 0.999M |
| Actinium Pharmaceuticals Inc | 1.192M |
| MAIA Biotechnology Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.102M |
| Cash from Investing (Quarterly) | -1.00M |
| Free Cash Flow | -7.291M |
| Free Cash Flow Per Share (Quarterly) | -0.4257 |
| Free Cash Flow Yield | -297.4% |